nodes	percent_of_prediction	percent_of_DWPC	metapath
Tirofiban—ITGB3—MFAP5-mediated ovarian cancer cell motility and invasiveness—TNNC1—dilated cardiomyopathy	0.051	0.0609	CbGpPWpGaD
Tirofiban—ITGA2B—myocardium—dilated cardiomyopathy	0.0433	0.433	CbGeAlD
Tirofiban—ITGA2B—heart—dilated cardiomyopathy	0.0303	0.302	CbGeAlD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0269	0.0321	CbGpPWpGaD
Tirofiban—ITGB3—heart—dilated cardiomyopathy	0.0264	0.264	CbGeAlD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—MYPN—dilated cardiomyopathy	0.0211	0.0253	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—SGCD—dilated cardiomyopathy	0.0207	0.0248	CbGpPWpGaD
Tirofiban—ITGA2B—Beta3 integrin cell surface interactions—LAMA4—dilated cardiomyopathy	0.0165	0.0198	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—MYPN—dilated cardiomyopathy	0.0163	0.0195	CbGpPWpGaD
Tirofiban—Acute myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0148	0.232	CcSEcCtD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.0141	0.0169	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—LAMA4—dilated cardiomyopathy	0.0136	0.0162	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—LAMA4—dilated cardiomyopathy	0.013	0.0155	CbGpPWpGaD
Tirofiban—ITGB3—Beta3 integrin cell surface interactions—LAMA4—dilated cardiomyopathy	0.0127	0.0152	CbGpPWpGaD
Tirofiban—ITGA2B—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.0119	0.0143	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—DSG2—dilated cardiomyopathy	0.0109	0.013	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.0107	0.0128	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.0107	0.0127	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—LAMA4—dilated cardiomyopathy	0.0104	0.0125	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.00995	0.0119	CbGpPWpGaD
Tirofiban—ITGA2B—Signal transduction by L1—ITGB1—dilated cardiomyopathy	0.00948	0.0113	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.00935	0.0112	CbGpPWpGaD
Tirofiban—ITGB3—Hematopoietic Stem Cell Differentiation—CSF3—dilated cardiomyopathy	0.0092	0.011	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—TTN—dilated cardiomyopathy	0.00879	0.0105	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—DMD—dilated cardiomyopathy	0.00859	0.0103	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.00846	0.0101	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—SIK1—dilated cardiomyopathy	0.0084	0.01	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00837	0.01	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—DES—dilated cardiomyopathy	0.00824	0.00986	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—SCN5A—dilated cardiomyopathy	0.00821	0.00982	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.00811	0.0097	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin family cell surface interactions—ITGB1—dilated cardiomyopathy	0.00799	0.00956	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—EMD—dilated cardiomyopathy	0.00766	0.00916	CbGpPWpGaD
Tirofiban—ITGA2B—Signal transduction by L1—RAC1—dilated cardiomyopathy	0.00762	0.00911	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00762	0.00911	CbGpPWpGaD
Tirofiban—ITGB3—Syndecan interactions—ITGB1—dilated cardiomyopathy	0.00759	0.00908	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—ITGB1—dilated cardiomyopathy	0.0073	0.00873	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00726	0.00868	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—RYR2—dilated cardiomyopathy	0.0072	0.00861	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.00709	0.00848	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.00688	0.00822	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—TTN—dilated cardiomyopathy	0.00677	0.00809	CbGpPWpGaD
Tirofiban—ITGA2B—Arf6 signaling events—ADRB2—dilated cardiomyopathy	0.00652	0.0078	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—DSP—dilated cardiomyopathy	0.00651	0.00779	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—VCL—dilated cardiomyopathy	0.00648	0.00775	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—TTN—dilated cardiomyopathy	0.00645	0.00771	CbGpPWpGaD
Tirofiban—ITGA2B—Ephrin B reverse signaling—RAC1—dilated cardiomyopathy	0.00642	0.00768	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ACTN2—dilated cardiomyopathy	0.00625	0.00747	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00617	0.00738	CbGpPWpGaD
Tirofiban—ITGB3—Integrin family cell surface interactions—ITGB1—dilated cardiomyopathy	0.00616	0.00736	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—VCL—dilated cardiomyopathy	0.00604	0.00722	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—RAC1—dilated cardiomyopathy	0.00587	0.00702	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—ACTN2—dilated cardiomyopathy	0.00587	0.00702	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—VCL—dilated cardiomyopathy	0.00568	0.0068	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—ACTN2—dilated cardiomyopathy	0.00559	0.00669	CbGpPWpGaD
Tirofiban—ITGB3—Molecules associated with elastic fibres—ITGB1—dilated cardiomyopathy	0.00549	0.00657	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—DMD—dilated cardiomyopathy	0.00546	0.00653	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—VCL—dilated cardiomyopathy	0.00543	0.00649	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—VCL—dilated cardiomyopathy	0.00542	0.00648	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—AGTR1—dilated cardiomyopathy	0.0053	0.00633	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—LAMA4—dilated cardiomyopathy	0.00503	0.00602	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—ADRB2—dilated cardiomyopathy	0.00502	0.00601	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—VCL—dilated cardiomyopathy	0.00499	0.00597	CbGpPWpGaD
Tirofiban—ITGB3—Ephrin B reverse signaling—RAC1—dilated cardiomyopathy	0.00495	0.00592	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00486	0.00581	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—VCL—dilated cardiomyopathy	0.00475	0.00568	CbGpPWpGaD
Tirofiban—ITGB3—Nectin adhesion pathway—RAC1—dilated cardiomyopathy	0.00441	0.00528	CbGpPWpGaD
Tirofiban—ITGA2B—ECM proteoglycans—ITGB1—dilated cardiomyopathy	0.00439	0.00525	CbGpPWpGaD
Tirofiban—ITGB3—Osteopontin-mediated events—RAC1—dilated cardiomyopathy	0.0043	0.00514	CbGpPWpGaD
Tirofiban—ITGB3—Elastic fibre formation—ITGB1—dilated cardiomyopathy	0.00428	0.00511	CbGpPWpGaD
Tirofiban—ITGB3—Non-integrin membrane-ECM interactions—ITGB1—dilated cardiomyopathy	0.00419	0.00502	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—ITGB1—dilated cardiomyopathy	0.00419	0.00502	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—VCL—dilated cardiomyopathy	0.00417	0.00499	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—SCN5A—dilated cardiomyopathy	0.00403	0.00482	CbGpPWpGaD
Tirofiban—ITGB3—Monoamine Transport—AGT—dilated cardiomyopathy	0.004	0.00479	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.0039	0.00466	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—LAMA4—dilated cardiomyopathy	0.00388	0.00464	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00387	0.00463	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin cell surface interactions—ITGB1—dilated cardiomyopathy	0.00379	0.00454	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00379	0.00453	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—LMNA—dilated cardiomyopathy	0.00374	0.00447	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00365	0.00437	CbGpPWpGaD
Tirofiban—Haemoptysis—Lisinopril—dilated cardiomyopathy	0.00364	0.0571	CcSEcCtD
Tirofiban—ITGA2B—Signal transduction by L1—EGFR—dilated cardiomyopathy	0.00347	0.00414	CbGpPWpGaD
Tirofiban—ITGA2B—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00346	0.00414	CbGpPWpGaD
Tirofiban—ITGB3—ECM proteoglycans—ITGB1—dilated cardiomyopathy	0.00338	0.00404	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.00338	0.00404	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—RAC1—dilated cardiomyopathy	0.00337	0.00403	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—VCL—dilated cardiomyopathy	0.00324	0.00388	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—SCN5A—dilated cardiomyopathy	0.0031	0.00371	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—TTN—dilated cardiomyopathy	0.003	0.00359	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—LAMA4—dilated cardiomyopathy	0.00298	0.00356	CbGpPWpGaD
Tirofiban—Swelling—Furosemide—dilated cardiomyopathy	0.00296	0.0464	CcSEcCtD
Tirofiban—ITGB3—Integrin cell surface interactions—ITGB1—dilated cardiomyopathy	0.00292	0.00349	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ZIC3—dilated cardiomyopathy	0.00292	0.00349	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00287	0.00344	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00287	0.00344	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—dilated cardiomyopathy	0.00281	0.00336	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00281	0.00336	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—IL10—dilated cardiomyopathy	0.00281	0.00336	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet degranulation—CD36—dilated cardiomyopathy	0.00277	0.00332	CbGpPWpGaD
Tirofiban—ITGB3—IL4-mediated signaling events—RPS6KB1—dilated cardiomyopathy	0.00273	0.00327	CbGpPWpGaD
Tirofiban—ITGB3—Primary Focal Segmental Glomerulosclerosis FSGS—ITGB1—dilated cardiomyopathy	0.00273	0.00326	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—ITGB1—dilated cardiomyopathy	0.00272	0.00325	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—RPS6KB1—dilated cardiomyopathy	0.0027	0.00323	CbGpPWpGaD
Tirofiban—ITGB3—Signal transduction by L1—EGFR—dilated cardiomyopathy	0.00267	0.00319	CbGpPWpGaD
Tirofiban—ITGB3—Arrhythmogenic Right Ventricular Cardiomyopathy—ITGB1—dilated cardiomyopathy	0.00267	0.00319	CbGpPWpGaD
Tirofiban—ITGA2B—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00264	0.00316	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—ACTN2—dilated cardiomyopathy	0.0026	0.00311	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.0026	0.00311	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00256	0.00306	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—VCL—dilated cardiomyopathy	0.0025	0.00299	CbGpPWpGaD
Tirofiban—ITGB3—Integrins in angiogenesis—RAC1—dilated cardiomyopathy	0.00244	0.00292	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00236	0.037	CcSEcCtD
Tirofiban—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00231	0.0362	CcSEcCtD
Tirofiban—ITGA2B—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.0023	0.00275	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00226	0.0027	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—SCN5A—dilated cardiomyopathy	0.00221	0.00265	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—VCL—dilated cardiomyopathy	0.00221	0.00265	CbGpPWpGaD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—RAC1—dilated cardiomyopathy	0.00219	0.00261	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—ITGB1—dilated cardiomyopathy	0.00216	0.00259	CbGpPWpGaD
Tirofiban—ITGB3—Platelet degranulation—CD36—dilated cardiomyopathy	0.00214	0.00256	CbGpPWpGaD
Tirofiban—ITGB3—Cell surface interactions at the vascular wall—ITGB1—dilated cardiomyopathy	0.00211	0.00253	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—ITGB1—dilated cardiomyopathy	0.0021	0.00251	CbGpPWpGaD
Tirofiban—ITGB3—Response to elevated platelet cytosolic Ca2+—CD36—dilated cardiomyopathy	0.00204	0.00243	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—TTN—dilated cardiomyopathy	0.00201	0.0024	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—PSEN1—dilated cardiomyopathy	0.002	0.00239	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—DMD—dilated cardiomyopathy	0.00197	0.00236	CbGpPWpGaD
Tirofiban—Sweating—Furosemide—dilated cardiomyopathy	0.00193	0.0302	CcSEcCtD
Tirofiban—Urticaria—Spironolactone—dilated cardiomyopathy	0.00187	0.0294	CcSEcCtD
Tirofiban—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00186	0.0292	CcSEcCtD
Tirofiban—ITGB3—Monoamine Transport—TNF—dilated cardiomyopathy	0.00181	0.00217	CbGpPWpGaD
Tirofiban—ITGB3—Arf6 signaling events—EGFR—dilated cardiomyopathy	0.00177	0.00212	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ACTN2—dilated cardiomyopathy	0.00174	0.00208	CbGpPWpGaD
Tirofiban—ITGB3—L1CAM interactions—RAC1—dilated cardiomyopathy	0.00174	0.00208	CbGpPWpGaD
Tirofiban—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00174	0.0272	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—PSEN2—dilated cardiomyopathy	0.0017	0.00203	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—RAC1—dilated cardiomyopathy	0.00168	0.00201	CbGpPWpGaD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—ITGB1—dilated cardiomyopathy	0.00168	0.00201	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling events mediated by PTP1B—EGFR—dilated cardiomyopathy	0.00168	0.00201	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.00163	0.00195	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—RAC1—dilated cardiomyopathy	0.0016	0.00191	CbGpPWpGaD
Tirofiban—Dizziness—Spironolactone—dilated cardiomyopathy	0.00156	0.0244	CcSEcCtD
Tirofiban—ITGB3—Hemostasis—TTN—dilated cardiomyopathy	0.00155	0.00185	CbGpPWpGaD
Tirofiban—ITGB3—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—dilated cardiomyopathy	0.00153	0.00183	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by VEGFR1 and VEGFR2—RAF1—dilated cardiomyopathy	0.00152	0.00182	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—RAC1—dilated cardiomyopathy	0.00151	0.0018	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—VCL—dilated cardiomyopathy	0.00148	0.00177	CbGpPWpGaD
Tirofiban—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00148	0.0232	CcSEcCtD
Tirofiban—Headache—Spironolactone—dilated cardiomyopathy	0.00148	0.0232	CcSEcCtD
Tirofiban—ITGA2B—Integrin-mediated Cell Adhesion—RAF1—dilated cardiomyopathy	0.00145	0.00173	CbGpPWpGaD
Tirofiban—Sweating—Lisinopril—dilated cardiomyopathy	0.00145	0.0227	CcSEcCtD
Tirofiban—Haematuria—Lisinopril—dilated cardiomyopathy	0.00144	0.0226	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—RAC1—dilated cardiomyopathy	0.00141	0.00168	CbGpPWpGaD
Tirofiban—Nausea—Spironolactone—dilated cardiomyopathy	0.0014	0.022	CcSEcCtD
Tirofiban—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00138	0.0216	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—RAC1—dilated cardiomyopathy	0.00135	0.00161	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ACTN2—dilated cardiomyopathy	0.00134	0.0016	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—RAC1—dilated cardiomyopathy	0.00131	0.00156	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—PSEN2—dilated cardiomyopathy	0.00131	0.00156	CbGpPWpGaD
Tirofiban—ITGB3—Signaling events mediated by PTP1B—EGFR—dilated cardiomyopathy	0.00129	0.00155	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00128	0.0201	CcSEcCtD
Tirofiban—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00126	0.0197	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—ITGB1—dilated cardiomyopathy	0.00125	0.0015	CbGpPWpGaD
Tirofiban—ITGA2B—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.00125	0.0015	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00124	0.0194	CcSEcCtD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.00123	0.00147	CbGpPWpGaD
Tirofiban—Chills—Lisinopril—dilated cardiomyopathy	0.00121	0.0191	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—PSEN2—dilated cardiomyopathy	0.00121	0.00145	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.00116	0.00139	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—VCL—dilated cardiomyopathy	0.00114	0.00136	CbGpPWpGaD
Tirofiban—ITGB3—Integrin-mediated Cell Adhesion—RAF1—dilated cardiomyopathy	0.00112	0.00134	CbGpPWpGaD
Tirofiban—Pain—Furosemide—dilated cardiomyopathy	0.0011	0.0172	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—ITGB1—dilated cardiomyopathy	0.00106	0.00127	CbGpPWpGaD
Tirofiban—ITGB3—VEGFA-VEGFR2 Pathway—RAF1—dilated cardiomyopathy	0.00106	0.00127	CbGpPWpGaD
Tirofiban—ITGA2B—L1CAM interactions—EGFR—dilated cardiomyopathy	0.00103	0.00123	CbGpPWpGaD
Tirofiban—Urticaria—Furosemide—dilated cardiomyopathy	0.00102	0.016	CcSEcCtD
Tirofiban—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00101	0.0159	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—RAC1—dilated cardiomyopathy	0.00101	0.00121	CbGpPWpGaD
Tirofiban—ITGB3—Signaling by VEGF—RAF1—dilated cardiomyopathy	0.000999	0.00119	CbGpPWpGaD
Tirofiban—ITGB3—Extracellular matrix organization—ITGB1—dilated cardiomyopathy	0.000964	0.00115	CbGpPWpGaD
Tirofiban—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.000962	0.0151	CcSEcCtD
Tirofiban—Oedema—Lisinopril—dilated cardiomyopathy	0.000962	0.0151	CcSEcCtD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—CD36—dilated cardiomyopathy	0.000948	0.00113	CbGpPWpGaD
Tirofiban—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.000945	0.0148	CcSEcCtD
Tirofiban—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.000942	0.0148	CcSEcCtD
Tirofiban—ITGB3—PDGFR-beta signaling pathway—RAF1—dilated cardiomyopathy	0.000934	0.00112	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—PSEN2—dilated cardiomyopathy	0.000933	0.00112	CbGpPWpGaD
Tirofiban—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00093	0.0146	CcSEcCtD
Tirofiban—ITGB3—TGF-beta Signaling Pathway—RAF1—dilated cardiomyopathy	0.000894	0.00107	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—RAC1—dilated cardiomyopathy	0.000893	0.00107	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000868	0.00104	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—RAC1—dilated cardiomyopathy	0.000854	0.00102	CbGpPWpGaD
Tirofiban—Dizziness—Furosemide—dilated cardiomyopathy	0.000848	0.0133	CcSEcCtD
Tirofiban—Pain—Lisinopril—dilated cardiomyopathy	0.000823	0.0129	CcSEcCtD
Tirofiban—ITGB3—Axon guidance—ITGB1—dilated cardiomyopathy	0.000818	0.000978	CbGpPWpGaD
Tirofiban—Headache—Furosemide—dilated cardiomyopathy	0.000803	0.0126	CcSEcCtD
Tirofiban—ITGB3—L1CAM interactions—EGFR—dilated cardiomyopathy	0.000791	0.000946	CbGpPWpGaD
Tirofiban—ITGA2B—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000769	0.000919	CbGpPWpGaD
Tirofiban—Urticaria—Lisinopril—dilated cardiomyopathy	0.000764	0.012	CcSEcCtD
Tirofiban—Nausea—Furosemide—dilated cardiomyopathy	0.000762	0.0119	CcSEcCtD
Tirofiban—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00076	0.0119	CcSEcCtD
Tirofiban—ITGA2B—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000758	0.000906	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—ITGB1—dilated cardiomyopathy	0.000743	0.000889	CbGpPWpGaD
Tirofiban—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.000709	0.0111	CcSEcCtD
Tirofiban—ITGB3—Focal Adhesion—RAF1—dilated cardiomyopathy	0.000668	0.000799	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—RAC1—dilated cardiomyopathy	0.000658	0.000786	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—CD36—dilated cardiomyopathy	0.000646	0.000773	CbGpPWpGaD
Tirofiban—Dizziness—Lisinopril—dilated cardiomyopathy	0.000636	0.00998	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—CD36—dilated cardiomyopathy	0.000634	0.000758	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—RAC1—dilated cardiomyopathy	0.000609	0.000729	CbGpPWpGaD
Tirofiban—Headache—Lisinopril—dilated cardiomyopathy	0.000603	0.00945	CcSEcCtD
Tirofiban—ITGA2B—Hemostasis—RAC1—dilated cardiomyopathy	0.000598	0.000715	CbGpPWpGaD
Tirofiban—ITGA2B—Focal Adhesion—EGFR—dilated cardiomyopathy	0.000595	0.000712	CbGpPWpGaD
Tirofiban—ITGB3—Platelet activation, signaling and aggregation—RAF1—dilated cardiomyopathy	0.000592	0.000708	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—ITGB1—dilated cardiomyopathy	0.000584	0.000698	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—ITGB1—dilated cardiomyopathy	0.000573	0.000685	CbGpPWpGaD
Tirofiban—Nausea—Lisinopril—dilated cardiomyopathy	0.000571	0.00896	CcSEcCtD
Tirofiban—ITGA2B—Axon guidance—RAF1—dilated cardiomyopathy	0.000566	0.000677	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—CD36—dilated cardiomyopathy	0.000498	0.000596	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—CD36—dilated cardiomyopathy	0.000489	0.000584	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RAC1—dilated cardiomyopathy	0.000469	0.000561	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—RAC1—dilated cardiomyopathy	0.00046	0.000551	CbGpPWpGaD
Tirofiban—ITGB3—Focal Adhesion—EGFR—dilated cardiomyopathy	0.000458	0.000548	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—RAF1—dilated cardiomyopathy	0.000436	0.000522	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—RAF1—dilated cardiomyopathy	0.000404	0.000483	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000403	0.000482	CbGpPWpGaD
Tirofiban—ITGA2B—Hemostasis—RAF1—dilated cardiomyopathy	0.000396	0.000474	CbGpPWpGaD
Tirofiban—ITGA2B—Axon guidance—EGFR—dilated cardiomyopathy	0.000388	0.000464	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000358	0.000428	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000358	0.000428	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000333	0.000398	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000322	0.000385	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—RAF1—dilated cardiomyopathy	0.000311	0.000372	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00031	0.000371	CbGpPWpGaD
Tirofiban—ITGB3—Hemostasis—RAF1—dilated cardiomyopathy	0.000305	0.000365	CbGpPWpGaD
Tirofiban—ITGB3—Axon guidance—EGFR—dilated cardiomyopathy	0.000299	0.000358	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—EGFR—dilated cardiomyopathy	0.000277	0.000331	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000276	0.00033	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000276	0.00033	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000275	0.000329	CbGpPWpGaD
Tirofiban—ITGA2B—Developmental Biology—TNF—dilated cardiomyopathy	0.000264	0.000315	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000261	0.000312	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000256	0.000306	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000248	0.000297	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000224	0.000268	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—EGFR—dilated cardiomyopathy	0.000213	0.000255	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000212	0.000253	CbGpPWpGaD
Tirofiban—ITGB3—Developmental Biology—TNF—dilated cardiomyopathy	0.000203	0.000243	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000203	0.000242	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000201	0.00024	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000194	0.000232	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000173	0.000207	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000156	0.000187	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000149	0.000178	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000134	0.000161	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000103	0.000124	CbGpPWpGaD
Tirofiban—ITGA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	9.21e-05	0.00011	CbGpPWpGaD
Tirofiban—ITGB3—Signaling Pathways—EGFR—dilated cardiomyopathy	7.1e-05	8.49e-05	CbGpPWpGaD
